CompletedNot Applicable

The Efficacy of Integrated Behavioral Therapy for Selective Mutism

Israel60 participantsStarted 2017-05-14

Plain-language summary

This study examines the efficacy of the Integrated Behavioral Therapy for Selective Mutism protocol (Bergman et al., 2013). Participants are 60 children, aged 4-8 years, diagnosed with Selective Mutism (SM). The level of SM symptoms is assessed during first arrival to the SM unit of Schneider Children's Medical Center of Israel (Intake), at the first treatment session, at sessions 12, and at the end of treatment. A secondary aim of this study is to assess the contribution of parent's characteristics (anxiety and depression levels, parenting style) to the childrens' SM symptoms level and to treatment achievements.

Who can participate

Age range4 Years – 8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Selective Mutism diagnosis (DSM-5) * age 4-8 years Exclusion Criteria: * Autism Spectum Disorder * Psychotic disorder * Commenced other psychiatric or psychological treatment at the last month

What they're measuring

Change in Selective Mutism Questionnaire

Timeframe: baseline, 1 week from baseline, 12 weeks from baseline, 24 weeks from baseline

Trial details

NCT IDNCT04585048

SponsorRabin Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-01

View on ClinicalTrials.gov More Selective Mutism trials